What is this medicine used for?
FDA-approved uses
- Partial-onset seizures — Adults; pediatric monotherapy from 4 and adjunctive therapy from 2. Age and treatment context determine dosing.Trileptal immediate-release tablets; Trileptal oral suspension.
- Partial-onset seizures — Adults and children age 6 or older. Once-daily empty-stomach administration.Oxtellar XR extended-release tablets.
Other uses (off-label)
Off-label means a medicine is prescribed for a use, age group or form that is not included in its FDA approval.
- Bipolar disorder — Selected patients under clinician supervision. Off-label; seizure approvals do not establish psychiatric efficacy or dosing.Trileptal immediate-release tablets; Trileptal oral suspension; Oxtellar XR extended-release tablets.
What should I expect?
For seizures, the aim is better seizure control with tolerable side effects as treatment is adjusted. Dizziness, sleepiness or visual changes can appear early.
Psychiatric use is off-label and has no established universal response timeline. Agree on the symptom being targeted and when the prescriber will decide whether continuing is worthwhile.
How do I take it safely?
Immediate-release tablets or liquid are generally taken twice daily, with or without food. Shake and measure the liquid with the supplied device. Oxtellar XR is taken once daily on an empty stomach, at least one hour before or two hours after food; swallow it whole.
Kidney function can alter dosing. Follow sodium levels when risks or symptoms warrant, especially with other sodium-lowering medicines. Tell the clinician about a carbamazepine allergy; cross-reactions occur. Discuss ancestry-related skin-reaction testing when applicable.
Hormonal contraception may be less effective; discuss additional or alternative protection. Review all medicines and avoid alcohol or other unreviewed sedatives. Discuss pregnancy and breastfeeding without suddenly stopping treatment. Immediate- and extended-release pediatric approvals differ.
Do not stop abruptly. Ask for the exact product’s missed-dose plan, and never double. If several doses were missed, call before restarting the previous regimen.
Do not use after a serious allergy to oxcarbazepine or eslicarbazepine acetate.
Do not use this product after a known allergy to its active medicine or ingredients; tell the pharmacist about previous medication reactions.
What side effects should I know about?
- Dizziness, sedation, double vision, nausea and poor coordination.
Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.
Looking for more detailed information?
The official medicine information lists more side effects, safety advice and product instructions.
- View FDA Prescribing Information (PDF) (opens in a new tab)TRILEPTAL- oxcarbazepine tablet, film coated
- View FDA Prescribing Information (PDF) (opens in a new tab)OXTELLAR XR- oxcarbazepine tablet
Which warning signs need help?
- A new rash, blistering, mouth sores, fever or swollen glands can signal a serious skin or multiorgan reaction and needs urgent assessment. Seek emergency care for a seizure, collapse, serious breathing difficulty, facial or throat swelling, or suspected overdose.
- Promptly report confusion, marked weakness, headache with nausea or worsening seizures; low sodium can be the cause. Contact the prescriber promptly for new suicidal thoughts, worsening depression or unusual behavior. Use emergency care if there is immediate danger or the person cannot stay safe.
What else should I know to stay safe?
- Do not use after allergy to oxcarbazepine, eslicarbazepine or product ingredients. A previous carbamazepine allergy and ancestry-related skin-reaction risks need review.
- Kidney function affects dosing. Monitor sodium when risks or symptoms warrant, particularly with other medicines that lower it. Hormonal contraception may be less effective; discuss reliable additional or alternative protection.
- Avoid alcohol and unreviewed sedatives. Discuss pregnancy and breastfeeding; pediatric approvals differ by release form. Do not stop abruptly or restart after repeated missed doses without the prescriber’s advice.
Urgent help and crisis support · Emergency & Crisis Resources (US)
What can help day to day?
- Food instructions differ: immediate-release medicine can be taken with or without food, while Oxtellar XR is taken on an empty stomach.
- New confusion, weakness or worsening seizures can reflect low blood sodium. They should not automatically be attributed to the original condition.
How does it work?
Oxcarbazepine is changed in the body into an active substance called MHD, which accounts for much of the medicine’s activity. Laboratory studies suggest that oxcarbazepine and MHD can reduce repeated nerve-cell firing by affecting sodium channels. The complete explanation for their antiseizure effect has not been established.
How was this medicine developed?
Trileptal tablets were approved in 2000 and Oxtellar XR in 2012. The extended-release product changed delivery and meal instructions; it did not establish an FDA approval for bipolar disorder.
How do I say the name?
Oxcarbazepine: ox-kar-BAZ-e-peen. Capital letters show the stressed syllable.
Medicine forms and official information
Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.
Choose a formulation
Immediate-release tablets
Twice-daily schedule.
Oral suspension
300 mg/5 mL; shake and measure accurately.
Extended-release tablets
Once daily fasting; conversion may require a higher dose.
Sources and References
Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.
- Oxcarbazepine: patient medicine information
- Oxcarbazepine: current prescribing information — mechanism explanation
Scope: Mechanism explanation only. Source sections checked: 12.1 Mechanism of Action; 12.3 Pharmacokinetics..
- Oxcarbazepine: FDA approval history
- Oxtellar XR prescribing information
- Oxtellar XR FDA approval history
- Oxcarbazepine: FDA prescribing information
- Oxcarbazepine: Package Insert / Prescribing Info / MOA
- Carbamazepine / Equetro: prescribing information
- Oxcarbazepine: verified neutral parent, PubChem CID 34312
- ISMP List of Confused Drug Names
- ISMP List of High-Alert Medications in Community/Ambulatory Care Settings
Giving medicine safely to children: family guide (PDF, 3 pages)

